Loading clinical trials...
Loading clinical trials...
Physiologic Effects of High-Dose Gastric Antral Botulinum Toxin Injections
Conditions
Interventions
BTA
Placebo (normal saline)
Locations
1
United States
Mayo Clinic
Rochester, Minnesota, United States
Start Date
September 1, 2009
Primary Completion Date
September 1, 2011
Completion Date
September 1, 2011
Last Updated
January 3, 2013
NCT01143454
NCT07472881
NCT07010757
NCT06989203
NCT06223555
NCT07237750
Lead Sponsor
Mayo Clinic
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions